Physician profile
Wade Faerber
NPI 1700856713
$79,418.33
in general payments reported to CMS, 2019-2025
24 companies · $3,266 in 2025
The $3,266 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,803 · 2020: $1,025 · 2021: $2,097 · 2022: $68K · 2023: $1,203 · 2024: $1,856 · 2025: $3,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,617 · Travel and Lodging: $1,911 · Grant: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,617.28 |
| Travel and Lodging | $1,911.49 |
| Grant | $796.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $65,733.47 | 2022 | |
| Acumed LLC | $8,030.36 | 2019-2025 | Acumed, Acumed, Innate Implant |
| Stryker Corporation | $1,525.78 | 2019-2025 | Mako, T2, Insignia |
| Depuy Synthes Sales INC. | $1,106.02 | 2019-2025 | Na, Hammerlock, Monovisc |
| Smith+Nephew, INC. | $548.79 | 2019-2022 | |
| Bioventus LLC | $381.42 | 2020-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Empire Medical, INC | $310.85 | 2022-2023 | |
| Integra Lifesciences Corporation | $291.82 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vital Orthopedics LLC | $249.75 | 2025 | |
| Miach Orthopaedics, INC. | $216.67 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $195.81 | 2019-2023 | Caldolor |
| Microport Orthopedics INC | $192.02 | 2023 | Mpo Hip System |
| Kci USA, INC. | $136.56 | 2019-2023 | Prevena |
| Convatec INC. | $97.44 | 2020 | |
| Wright Medical Technology, INC. | $90.11 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $78.80 | 2019 | |
| Trimed, INC. | $62.33 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $58.04 | 2024-2025 | |
| Abbvie INC. | $47.26 | 2025 | |
| Davol INC. | $25.69 | 2023 | |
| Pfizer INC. | $18.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.44 | 2019 | |
| Electronic Waveform Lab, INC. | $3.14 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$194,183.04 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Faerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.